Crispr Therapeutics Ag (CRSP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 12-2014 | 06-2006 | |
| Sales | 476 | 0 | 0 | 0 | 0 |
| Gross Profit | 476 | N/A | N/A | N/A | 0 |
| Operating Expenses | 12,128 | 0 | 6,202 | 0 | 0 |
| Operating Income | -11,652 | N/A | -6,202 | N/A | 0 |
| Interest Expense | 8,050 | 0 | 8 | 0 | 0 |
| Other Income | 11,336 | 0 | 9 | 0 | 0 |
| Pre-tax Income | -8,366 | 0 | -6,201 | 0 | 0 |
| Income Tax | 76 | N/A | 153 | N/A | 0 |
| Net Income Continuous | -8,442 | N/A | -6,354 | N/A | 0 |
| Minority Interests | -3 | N/A | -1 | N/A | 0 |
| Net Income | $-8,439 | $N/A | $-6,353 | $N/A | $0 |
| EPS Basic Total Ops | -1.53 | N/A | -1.15 | N/A | N/A |
| EPS Basic Continuous Ops | -1.53 | N/A | -1.15 | N/A | N/A |
| EPS Diluted Total Ops | -1.53 | N/A | -1.15 | N/A | N/A |
| EPS Diluted Continuous Ops | -1.53 | N/A | -1.15 | N/A | N/A |
| EBITDA(a) | $-11,546 | $N/A | $-6,202 | $N/A | $0 |